AUSTRALIA’S drugs watchdog today announced that psychedelic substances MDMA and psilocybin — more commonly known as ecstasy and magic mushrooms — will soon be used in the treatment of depression and post-traumatic stress.
Psychiatrists will be able to prescribe the two substances from July, the Therapeutic Goods Administration said after finding “sufficient evidence for potential benefits in certain patients”.